Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Latest News

  • News

    Liver injury linked to COVID-19–related coagulopathy

    November 18, 2020

    Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.

  • 1
    News

    One-third of critical illness survivors emerge from ICU with functional deterioration

    November 18, 2020

    One-third of patients who survived nonsurgical ICU admission had evidence of functional status decline.

  • 1
    News

    COVID-19 burdens follow patients after discharge

    November 18, 2020

    Postdischarge COVID-19 patients have high rates of long-term sequelae from sepsis and other severe respiratory viral illnesses.

  • News

    Metapneumovirus infections clinically indistinguishable from flu, RSV

    November 17, 2020

    Those at risk for severe or fatal metapneumovirus infections include frail elderly and patients with cardiovascular disease or compromised immunity.

  • News

    Cardiac arrest in COVID-19 pandemic: ‘Survival is possible’

    November 17, 2020

    Results of new studies of in- and out-of-hospital cardiac arrest underline that, despite lower survival rates during the pandemic, rates are “not zero,” and response is “not futile.”

  • News

    In those with obesity, will losing weight cut COVID-19 severity?

    November 17, 2020

    “To think excess weight may also be detrimental to acute effects of a novel virus running amok in the world has focused minds on obesity in a manner not seen before.”

  • 1
    News

    ‘Tragic’ milestone: 1 million children with COVID-19

    November 17, 2020

    “We haven’t seen a virus flash through our communities in this way since before we had vaccines for measles and polio.”

  • 1
    News

    New-onset AFib common but unrecognized in the month after cardiac surgery

    November 17, 2020

    Results of SEARCH-AF trial show one in five cardiac surgery patients with no history of atrial fibrillation develop it within 30 days post discharge.

  • 1
    News

    What hospitalists need to know about health care reimbursement and denial prevention

    November 17, 2020

    The most powerful tools in combating clinical denials for hospital services are good medicine and clear documentation.

  • Article

    Moderna: Interim data show 94.5% efficacy for COVID-19 vaccine, will seek FDA EUA

    November 16, 2020

    The first interim results of the phase 3 COVE trial included 95 participants with confirmed COVID-19.

Previous1 … 157 158 159 160 161 … 358Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences